Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Appointment of Associate Faculty Member at Sanger Institute

Published: Monday, April 08, 2013
Last Updated: Monday, April 08, 2013
Bookmark and Share
MISSION Co-Founder and CSO, Professor Steve Jackson appointed as Faculty Member.

MISSION Therapeutics (“MISSION”) has announced the recent appointment of the Company’s co-founder and Chief Scientific Officer, Professor Steve Jackson as Associate Faculty Member at the prestigious Wellcome Trust Sanger Institute.

Professor Jackson is a Fellow of both the Royal Society and the UK Academy of Medical Sciences, and since 1995 has held the Frederick James Quick Chair of Biology at the University of Cambridge, a post which he currently combines with Head of the Cancer Research UK Laboratories at the Gurdon Institute, Cambridge.

Professor Jackson takes a position within the Department of Human Genetics at the Sanger Institute, where his research will focus on the maintenance of genome stability.

His research group based at the Gurdon Institute, University of Cambridge and the new complementary group at the Sanger Institute are focused on the mechanistic understanding of DNA repair and damage responses in normal and diseased cells.

His Maintenance of Genome Stability team at the Sanger Institute will aim to understand precisely how cells respond to DNA damage.

This research will provide new insights into human cell biology and human disease, and may identify opportunities for developing new diagnostic tools and therapeutic agents.

The post of Associate Faculty Member gives Professor Jackson access to the world class research of the Sanger Institute, allowing his research teams to collaborate with other Sanger Institute researchers and draw on the wealth of resources within the Institute, particularly in cancer genetics.

"We are delighted to welcome such a distinguished basic and translational researcher as Steve Jackson to our Associate Faculty - a cadre of researchers whose skills complement our own and with whom we can build new opportunities for genomic exploration," says Professor Michael Stratton, Director of the Wellcome Trust Sanger Institute.

Professor Stratton continued, “Our collective aim is to build a portfolio of research that will contribute as rapidly as possible to therapeutic development and we very much look forward to achieving that goal with Steve.”

Dr Michael Moore, Chairman of the MISSION Board commented: “Steve’s appointment to the Associate Faculty position at the Sanger Institute is further testimony to his distinction and leadership position as a world-class scientist in the field of cancer genetics and of DNA repair. Steve’s contribution to the elucidation of disease mechanisms contributing to cancer and other disorders will stimulate the pursuit of new and more effective diagnostic and therapeutic approaches.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!